Skip to main content

ESMOLOL HYDROCHLORIDE MEDICIANZ (Medicianz Healthcare Pty Ltd)

Product name
ESMOLOL HYDROCHLORIDE MEDICIANZ
Date registered
Evaluation commenced
Decision date
Approval time
121 (255 working days)
Active ingredients
Esmolol hydrochloride
Registration type
New generic medicine
Indication

Supraventricular tachycardia

ESMOLOL MEDSURGE is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. ESMOLOL MEDSURGE is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. [TRADE NAME] is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

Help us improve the Therapeutic Goods Administration site